chlorproguanil-dapsone-artesunate

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Malaria, Falciparum

Phase 3

Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria

CompletedNCT00344006

GlaxoSmithKlineMalaria, Falciparum

Start: 2006-06-30End: 2007-08-31Updated: 2016-12-05

Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

CompletedNCT00371735

GlaxoSmithKlineMalaria, Falciparum

Start: 2006-04-30End: 2007-05-31Updated: 2016-12-05

Related Papers

Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.

2012-09-1985 citations

Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.

2011-08-1764 citations

Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.

2009-08-1947 citations